- 全部删除
- 您的购物车当前为空
Vatelizumab是一种靶向Integrin α2β1(very late antigen 2,VLA-2,CD49b)的人源化单克隆抗体,能够通过p38 MAPK信号来增强调节性T细胞的频率,可用于研究多发性硬化症。
Vatelizumab是一种靶向Integrin α2β1(very late antigen 2,VLA-2,CD49b)的人源化单克隆抗体,能够通过p38 MAPK信号来增强调节性T细胞的频率,可用于研究多发性硬化症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 2,480 | In stock | |
5 mg | ¥ 5,860 | In stock | |
10 mg | ¥ 7,890 | In stock | |
25 mg | ¥ 11,700 | In stock |
Vatelizumab 相关产品
产品描述 | Vatelizumab is a humanised monoclonal antibody targeting Integrin α2β1 (very late antigen 2, VLA-2, CD49b), which enhances the frequency of regulatory T cells via the p38 MAPK signalling pathway and can be used for research into multiple sclerosis. |
别名 | 伐利组单抗, TMC-2003, SAR 339658, GBR500, GBR 500, CHR-1103, CHR1103 |
CAS No. | 1238217-55-4 |
存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容